Xanthoma
Xanthoma jẹ ifisilẹ ti awọn ohun elo ti o ni idaabobo awọ ofeefee ti o le han nibikibi ninu ara ni ọpọlọpọ awọn ipinlẹ arun. Wọn jẹ awọn ifihan ti awọ ara ti lipidosis ninu eyiti awọn lipids kojọpọ ninu awọn sẹẹli foomu nla laarin awọ ara. Wọn ni nkan ṣe pẹlu hyperlipidemia.
☆ Ninu awọn abajade 2022 Stiftung Warentest lati Jẹmánì, itẹlọrun alabara pẹlu ModelDerm jẹ kekere diẹ ju pẹlu awọn ijumọsọrọ telemedicine isanwo.
Orunkun alaisan n ṣafihan ọpọlọpọ awọn egbo.
References
Xanthomas jẹ awọn ohun idogo ọra ninu ara. Lakoko ti wọn jẹ alaiṣe nigbagbogbo, wọn nigbagbogbo jẹ ami ti o han pataki ti awọn arun eto eto. Kii ṣe gbogbo eniyan ti o ni idaabobo awọ giga tabi awọn ipele ọra gba xanthomas, ṣugbọn iranran wọn le jẹ ami bọtini ti awọn ipo iṣelọpọ wọnyi.
Xanthomas are localized lipid deposits within an organ system. Although innately benign, they are often an important visible sign of systemic diseases. Not all patients with hyperlipidemia or hypercholesterolemia develop xanthomas. However, the presence of xanthomatous lesions can serve as a unique and important clinical indicator of these metabolic states.
Xanthomas are localized lipid deposits within an organ system. Although innately benign, they are often an important visible sign of systemic diseases. Not all patients with hyperlipidemia or hypercholesterolemia develop xanthomas. However, the presence of xanthomatous lesions can serve as a unique and important clinical indicator of these metabolic states.
